• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Prediction of unplanned discontinuation of treatment in patients with castration-resistant prostate cancer-results from the IBuTu study].

作者信息

Honecker F, Wedding U, Kallischnigg G, Schroeder A, Klier J, Frangenheim T, Weißbach L

机构信息

Tumor- und Brustzentrum St. Gallen, Rorschacher Str. 150, 9006, St. Gallen, Schweiz.

Abteilung für Onkologie, Hämatologie und Knochenmarktransplantation mit Sektion Pneumologie, Hubertus Wald Tumorzentrum, Universität Hamburg, Martinistraße 52, 20246, Hamburg, Deutschland.

出版信息

Urologe A. 2018 Aug;57(8):909-918. doi: 10.1007/s00120-018-0704-5.

DOI:10.1007/s00120-018-0704-5
PMID:29978302
Abstract
摘要

相似文献

1
[Prediction of unplanned discontinuation of treatment in patients with castration-resistant prostate cancer-results from the IBuTu study].[去势抵抗性前列腺癌患者治疗计划外中断的预测——来自IBuTu研究的结果]
Urologe A. 2018 Aug;57(8):909-918. doi: 10.1007/s00120-018-0704-5.
2
Risk factors for unplanned discontinuation of scheduled treatment in elderly patients with castration-resistant prostate cancer: results of the IBuTu study.去势抵抗性前列腺癌老年患者计划治疗中断的危险因素：IBuTu研究结果
J Cancer Res Clin Oncol. 2018 Mar;144(3):571-577. doi: 10.1007/s00432-017-2577-1. Epub 2018 Jan 4.
3
Prostate cancer: CYP17A1 inhibitor failure-lessons for future drug development.
Nat Rev Urol. 2015 May;12(5):245-6. doi: 10.1038/nrurol.2015.66. Epub 2015 Mar 31.
4
Efficacy and safety of docetaxel and prednisolone for castration-resistant prostate cancer: a multi-institutional retrospective study in Japan.多西他赛与泼尼松治疗去势抵抗性前列腺癌的疗效和安全性：日本多机构回顾性研究
Jpn J Clin Oncol. 2015 Jul;45(7):682-7. doi: 10.1093/jjco/hyv053. Epub 2015 Apr 10.
5
Reply to K. Lu.回复卢凯。
J Clin Oncol. 2015 Oct 1;33(28):3222-3. doi: 10.1200/JCO.2015.62.4692. Epub 2015 Jul 27.
6
Reply to K. Lu.回复K. 卢。
J Clin Oncol. 2015 Oct 1;33(28):3222. doi: 10.1200/JCO.2015.62.4684. Epub 2015 Jul 27.
7
A multicenter retrospective analysis of sequential treatment of abiraterone acetate followed by docetaxel in Japanese patients with metastatic castration-resistant prostate cancer.一项关于日本转移性去势抵抗性前列腺癌患者中醋酸阿比特龙序贯多西他赛治疗的多中心回顾性分析。
Jpn J Clin Oncol. 2015 Aug;45(8):774-9. doi: 10.1093/jjco/hyv070. Epub 2015 May 15.
8
The Negative Is Not So Negative: What Do We Learn From Trials With Orteronel?阴性结果并非如此消极：我们从奥曲奈试验中学到了什么？
J Clin Oncol. 2015 Oct 1;33(28):3221. doi: 10.1200/JCO.2015.62.3165. Epub 2015 Jul 27.
9
Prolonged biochemical response after discontinuation of orteronel (TAK-700) in a patient with metastasized castration-resistant prostate cancer.转移性去势抵抗性前列腺癌患者停用奥特雄胺（TAK-700）后出现的长期生化反应
Acta Oncol. 2016 May;55(5):656-8. doi: 10.3109/0284186X.2015.1118657. Epub 2016 Apr 4.
10
Re: Phase III, Randomized, Double-Blind, Multicenter Trial Comparing Orteronel (TAK-700) plus Prednisone with Placebo plus Prednisone in Patients with Metastatic Castration-Resistant Prostate Cancer that has Progressed during or after Docetaxel-Based Therapy: ELM-PC 5.回复：III期随机双盲多中心试验，比较奥替诺隆（TAK-700）联合泼尼松与安慰剂联合泼尼松用于多西他赛治疗期间或之后病情进展的转移性去势抵抗性前列腺癌患者：ELM-PC 5研究
J Urol. 2015 Oct;194(4):990. doi: 10.1016/j.juro.2015.07.010. Epub 2015 Jul 9.

本文引用的文献

1
Risk factors for unplanned discontinuation of scheduled treatment in elderly patients with castration-resistant prostate cancer: results of the IBuTu study.去势抵抗性前列腺癌老年患者计划治疗中断的危险因素：IBuTu研究结果
J Cancer Res Clin Oncol. 2018 Mar;144(3):571-577. doi: 10.1007/s00432-017-2577-1. Epub 2018 Jan 4.
2
Management of Prostate Cancer in Elderly Patients: Recommendations of a Task Force of the International Society of Geriatric Oncology.老年前列腺癌患者的管理：国际老年肿瘤学会工作组的建议。
Eur Urol. 2017 Oct;72(4):521-531. doi: 10.1016/j.eururo.2016.12.025. Epub 2017 Jan 11.
3
Predictive Comprehensive Geriatric Assessment in elderly prostate cancer patients: the prospective observational scoop trial results.
老年前列腺癌患者的预测性综合老年评估：前瞻性观察性SCOOP试验结果
Anticancer Drugs. 2017 Jan;28(1):104-109. doi: 10.1097/CAD.0000000000000428.
4
Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study.综合老年评估在晚期非小细胞肺癌老年患者管理中的应用：III期随机ESOGIA-GFPC-GECP 08-02研究
J Clin Oncol. 2016 May 1;34(13):1476-83. doi: 10.1200/JCO.2015.63.5839. Epub 2016 Feb 16.
5
Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology.老年前列腺癌患者的管理：国际老年肿瘤学会工作组的最新建议。
Lancet Oncol. 2014 Aug;15(9):e404-14. doi: 10.1016/S1470-2045(14)70018-X.
6
Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations†.筛查工具用于多维健康问题，这些问题需要对老年癌症患者进行老年评估：SIOG 建议的更新†。
Ann Oncol. 2015 Feb;26(2):288-300. doi: 10.1093/annonc/mdu210. Epub 2014 Jun 16.
7
End points and trial design in geriatric oncology research: a joint European organisation for research and treatment of cancer--Alliance for Clinical Trials in Oncology--International Society Of Geriatric Oncology position article.老年肿瘤学研究的终点和试验设计：欧洲癌症研究与治疗组织-肿瘤临床研究联盟-国际老年肿瘤学会的立场文章。
J Clin Oncol. 2013 Oct 10;31(29):3711-8. doi: 10.1200/JCO.2013.49.6125. Epub 2013 Sep 9.
8
The value of geriatric assessments in predicting treatment tolerance and all-cause mortality in older patients with cancer.老年评估在预测老年癌症患者的治疗耐受性和全因死亡率方面的价值。
Oncologist. 2012;17(11):1439-49. doi: 10.1634/theoncologist.2012-0186. Epub 2012 Aug 31.
9
Screening older cancer patients: first evaluation of the G-8 geriatric screening tool.老年癌症患者的筛查：G-8 老年综合评估工具的初步评估。
Ann Oncol. 2012 Aug;23(8):2166-2172. doi: 10.1093/annonc/mdr587. Epub 2012 Jan 16.
10
Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score.预测老年患者化疗毒性的风险：高龄患者化疗风险评估量表 (CRASH) 评分。
Cancer. 2012 Jul 1;118(13):3377-86. doi: 10.1002/cncr.26646. Epub 2011 Nov 9.